| Literature DB >> 33572391 |
Ilaria Cicalini1,2, Damiana Pieragostino1,3, Cristiano Rizzo4, Sara Verrocchio1,2, Daniela Semeraro1,2, Mirco Zucchelli1,3, Silvia Di Michele5, Carlo Dionisi-Vici4, Liborio Stuppia1,6, Vincenzo De Laurenzi1,3, Ines Bucci1,2, Claudia Rossi1,6.
Abstract
Biotinidase (BTD) deficiency is an autosomal recessive inherited neurocutaneous disorder. BTD recycles the vitamin biotin, a coenzyme essential for the function of four biotin-dependent carboxylases, including propionyl-CoA carboxylase, 3-methylcrotonyl-CoA carboxylase, pyruvate carboxylase, and acetyl-CoA carboxylase. Due to deficient activities of the carboxylases, BTD deficiency is also recognized as late-onset multiple carboxylase deficiency and is associated with secondary alterations in the metabolism of amino acids, carbohydrates, and fatty acids. BTD deficiency can be classified as "profound", with less than 10% of mean normal activity, and as "partial" with 10-30% of mean normal activity. Newborn screening (NBS) of BTD deficiency is performed in most countries and is able to detect both variants. Moreover, mild metabolic alterations related to carboxylase deficiency in profound BTD deficiency could result and possibly be revealed in the metabolic profile by tandem mass spectrometry (MS/MS) NBS. Here, we report the case of a newborn female infant with an initial suspected BTD deficiency at the NBS test, finally confirmed as a partial variant by molecular testing. Although BTD deficiency was partial, interestingly her metabolic profile at birth and during the follow-up tests revealed, for the first time, alterations in specific acylcarnitines as a possible result of the deficient activity of biotin-dependent carboxylases.Entities:
Keywords: biotinidase deficiency; inborn errors of metabolism; mass spectrometry; metabolic profiling; newborn screening
Year: 2021 PMID: 33572391 PMCID: PMC7916230 DOI: 10.3390/ijerph18041659
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390